[The use of follicle-stimulating hormone (FSH-P) for the induction of superovulation in cattle]. / Die Anwendung Follikel-stimulierender Hormone (FSH-P) zur Auslösung der Superovulation beim Rind.

The clinical effectiveness of FSH-P for initiating superovulation in cattle was examined in 948 animals of the breed Deutsche Schwarzbunte and Deutsche Rotbunte of RPN Verden during 1988 and 1989. In the group of the FSH-P treated animals the number of transferable embryos was 4.4 +/- 4 per animal. The 25% percentile was 1 and the 75% percentile was 7 transferable embryos per donor. In 88 animals no embryos were found. In animals with a large number of embryos there was a changed quotient between transferable embryos and non transferable embryos per animal. A seasonal dependence in the number of transferable embryos was not found. Repeated treatment with FSH-P seemed to have no influence on the number of transferable embryos per animal. In the dose range between 6.6-9.4 mg FSH-P no differences in the number of transferable embryos per animal were found.

[The clinical effectiveness of FSH-P for induction of superovulation in cattle]. / Untersuchung der klinishcen Wirksamkeit von FSH-P zur Auslösung der Superovulation beim Rind.

The clinical efficacy of FSH-P for the initiation of superovulation in cattle was examined on 1000 animals of the Deutsche Schwarzbunte and Rotbunte breeds of RPN Verden during the years 1988 and 1989. In untreated cattle only one embryo is found (R. J. Mapletoft 1983, Roselius 1989). In the group of the FSH-P treated animals, the number of transferable embryos was 5.8 +/- 3.6. The 25% percentile was 3 and the 75% percentile was 8. A seasonal dependence was not found.

[Effect of SL 25 on radiogenic xerostomia in the radiotherapy of tumors in the region of neck and face (author's transl)]. / Die Wirkung von SL 25 auf die radiogene Xerostomie bei der Strahlentherapie von Tumoren im Hals- und Gesichtsbereich.

The radiogenic xerostomia often poses problems to the radiotherapeutist because this symptom can become so severe that treatment has to be interrupted or in some cases even stopped. The therapeutic success can become uncertain because of such deviations from the irradiation scheme. Because of promising observations reported in literature, we have examined the stimulating effect on the salivation produced by the test preparation SL 25 from Kali-Chemie Pharma GmbH in Hannover. A double blindfold test was made. Only three out of fourteen patients (22%) in the active substance group declared to feel a relief of the xerostomia, whereas in the control group five out of twenty patients (25%) felt this relief.